Showing results (1091-1100 of 1,153) with videos related to
Sort By:
Pageof 116
The ISME Journal|March 30, 2016
Challenges in microbial ecology: building predictive understanding of community function and dynamicsStefanie Widder, Rosalind J Allen, Thomas Pfeiffer, et al.Genes, Chromosomes & Cancer|January 23, 2025
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q AberrationGioia Di Stefano, Anja Fischer, Emil Chteinberg, et al.Haematologica|May 6, 2022
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomasCristina Lopez, Nikolai Schleussner, Stephan H Bernhart, et al.Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.Leukemia|July 19, 2022
PARP14 is a novel target in STAT6 mutant follicular lymphomaMichael Mentz, William Keay, Carolin Dorothea Strobl, et al.Blood Advances|July 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatmentMalgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, et al.Haematologica|May 2, 2020
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progressionAntonio G Solimando, Matteo C Da Vià, Patrizia Leone, et al.Cancers|September 29, 2020
Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 TrialLara Mussolin, Marié-Cecilé Le Deley, Elisa Carraro, et al.Blood|October 5, 2018
IG-<i>MYC</i> <sup>+</sup> neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasRabea Wagener, Cristina López, Kortine Kleinheinz, et al.Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.Pageof 116